The cohort study for live-style associated liver disease
Latest Information Update: 03 Nov 2020
At a glance
- Drugs Exenatide (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- 10 Dec 2019 Status changed from active, no longer recruiting to completed.
- 16 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 19 May 2016 New trial record